PMH42 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED NORDIC COUNTRIES
| Autor: | L. Fonticoli, Balázs Nagy, K. Corcoran, Balint Nemeth, F. Lelli, R. Bendes, Zoltán Vokó |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Cost–utility analysis
medicine.medical_specialty Risperidone business.industry 030503 health policy & services Health Policy Public Health Environmental and Occupational Health Cariprazine medicine.disease 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Schizophrenia medicine 030212 general & internal medicine 0305 other medical science business Psychiatry medicine.drug |
| Zdroj: | Value in Health. 21:S281 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2018.09.1677 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect